Venous Thromboembolism Treatment Demand Analysis
Venous Thromboembolism Treatment Market: US Remains the Front Runner Driven by Favorable Reimbursement Scenario: Global Industry Analysis 2014-2018 and Opportunity Assessment 2019-2029
- Healthcare, Pharmaceuticals and Medical devices
- 2019-05-13
- REP-GB-1341
- 54 Tables
- 114 Figures
- 243 pages
-
Press Release:
Venous Thromboembolism Treatment – Devices Used for Deep Venous Thrombosis and Pulmonary Embolism Treatments
The demand for venous thromboembolism treatment devices is expected to increase due to the increasing prevalence of pulmonary embolism. The manufacturers of venous thromboembolism treatment devices are majorly focusing on mergers and acquisitions.
Market Set to Grow 1.5x between 2019 and 2029
The venous thromboembolism treatment market is likely to witness steady growth over the course of the forecast period. The increasing retrieval rate of vena cava filters and increasing number of vena cava surgical procedures are among factors driving the growth of the venous thromboembolism treatment market.
Emerging Countries Promise New Growth Opportunities
North America is expected to contribute the highest revenue share in the global venous thromboembolism treatment market in 2019. However, healthy growth is expected in developing countries, especially China, India, and South Korea. Among the emerging countries, India is likely to present significant growth opportunities of growth for stakeholders in the venous thromboembolism treatment market.
* This data is only a representation. Actual data may vary and will be available in report.
-
2014
-
2018
-
2022
-
2028
The Broader Perspective
Stakeholders in the venous thromboembolism treatment market are adapting to the evolving requirements of the healthcare community and the patient pool. Manufacturers are mainly focusing on mergers and acquisitions. For example, in early 2016, Argon Medical fully acquired the option elite retrievable IVCF, cleaner rotational thrombectomy system, and UltraStream Chronic Hemodialysis Catheter. Moreover, in July 2017, Cardinal Health announced that it has completed the acquisition of Medtronic's patient care, deep vein thrombosis, and nutritional insufficiency businesses for US$6.1 billion.
Catheter-Directed Thrombolysis (CDT) Devices – This segment has a significant share in the market and is expected to grow at a higher rate during the forecast period
Percutaneous Thrombectomy Devices – This segment is likely to hold a remarkable share in the venous thromboembolism treatment market
Segmented Pneumatic Compression Pumps without Gradient – This segment is expected to show a significant growth rate in the venous thromboembolism treatment market
Deep Venous Thrombosis – This segment is expected to account for 70% of the total revenue in the overall market
Pulmonary Embolism – Pulmonary embolism is expected to witness a slower growth rate as compared to the deep venous thrombosis segment
Hospitals - Hospitals remain the top end-users with nearly 55% revenue share
Catheterisation Laboratories – Catheterisation laboratories are expected to grow at a significant rate
Ambulatory Surgical Centres – This segment is expected to witness a low share in the overall market
How Growth will Unfold
loreum
Catheter-Directed Thrombolysis (CDT) Devices | Percutaneous Thrombectomy Devices | Segmented Pneumatic Compression Pumps without Gradient
* This data is only a representation. Actual data may vary and will be available in report.
Click Here To Know How The Growth Will UnfoldRead in-depth analysis on Venous Thromboembolism Treatment Demand Analysis
In-depth Opinion - Venous Thromboembolism Treatment Demand Analysis
Venous Thromboembolism Treatment Market - Key Research Findings
-
Global venous thromboembolism treatment market size in 2018 – Nearly US$ 1,200 Mn
-
The venous thromboembolism treatment market is expected to observe a CAGR of 4.0% over 2019-2029.
-
North America and Europe will reportedly continue to spearhead global market for venous thromboembolism treatment, through 2029.
-
The presence of favorable reimbursement policies in the U.S. is one of the major factors contributing to the growth of the venous thromboembolism treatment market.
-
Asia Pacific holds a high growth potential for the venous thromboembolism treatment market
-
Increasing healthcare awareness and increasing number of surgical procedures is expected to boost the growth of the venous thromboembolism treatment market.
Top 3 Factors Shaping the Venous Thromboembolism Treatment Market
-
Increasing Prevalence of Pulmonary Embolism
Increasing prevalence of pulmonary embolism disease is one of the major factors responsible for the growth of the venous thromboembolism treatment market. Several patients are at a very high risk of developing elevated levels of venous thromboembolism, and retrievable vena cava filters act as an aid to prevent the progression of fatal pulmonary embolism during bedside prophylactic treatment.
It is anticipated that the therapeutic application of vena cava filters will decrease globally due to several complications and risks associated when the device is not retrieved, and this is expected to accelerate the need for prophylactic filters for the treatment of such patient groups, which is another factor that is expected to boost the venous thromboembolism treatment market.
The number of surgical procedures is increasing globally, which is also expected to boost the growth of the venous thromboembolism treatment market. Venous thromboembolism devices enable physicians to work with greater flexibility and allow them to deliver drugs, fluids, and nutritional agents that are particularly useful for the treatment of these embolic patient groups, which is also expected to increase the overall growth of the venous thromboembolism treatment market.
-
Favourable Reimbursement Policies for Vena Cava Filter Procedures, Particularly in the U.S.
There are various favourable reimbursement policies, which can increase the overall growth of the venous thromboembolism treatment market. Several studies have reported that there is a strong correlation between the usage rate/adoption of prophylactic vena cava filters and a patient’s payer status. In 2012, a retrospective study on the usage of prophylactic filters carried out in U.S. found that there was 4.9% growth in the usage of prophylactic filters among patients with insurance coverage as compared to 2.7% in patient groups without any health insurance coverage.
The U.S. market is one of the largest revenue-generating regional markets for venous thromboembolism treatment. There are favourable reimbursement options for performing minimally invasive procedures in the country, which is expected to boost the growth of the venous thromboembolism treatment market. Moreover, the country offers physicians high incentives to use filters for prophylactic treatment. This factor is also likely to be responsible for the significant growth of the venous thromboembolism treatment market.
-
Increasing Retrieval Rate of Vena Cava Filters
Vena cava filters are associated with serious medical complications post-surgical implantation. Hence, these devices need to be removed once the risk of pulmonary embolism reduces. In 2013, a report based on the quantitative risk-benefit profiling of retrieval vena cava filters reported that these filters should be replaced in a span of approximately one to two months, post-surgery.
As awareness about the possible risks involved in case of vena cava filters being left inside patients is growing, there has been a push in the venous thromboembolism treatment industry for developing advanced tracking systems for patient follow-up as well as to ensure filter removal in these patients once the risk of pulmonary embolism gets minimised. The increasing retrieval rate of vena cava filters is thus expected to increase the growth of the venous thromboembolism treatment market.
Venous Thromboembolism Treatment Market Structure Analysis
-
In the global venous thromboembolism treatment market, tier 1 companies hold a revenue share of more than 35%.
-
Key players in the venous thromboembolism treatment market focus on collaborations and partnerships to increase their product portfolio.
-
Leading players in the venous thromboembolism treatment market are also trying to launch some new products in the venous thromboembolism treatment market.
-
Some of the key strategies adopted by the manufacturers of venous thromboembolism treatment are playing a major role in the growth of the venous thromboembolism treatment market.
Overview
Venous Thromboembolism Treatment Market: Global Industry Analysis 2014-2018 & Opportunity Assessment 2019-2029
A recent market study published by FMI “Venous Thromboembolism Treatment Market: Global Industry Analysis 2014-2018 & Forecast 2019-2029” offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historic as well as current growth parameters of the venous thromboembolism treatment market, the growth prospects of the market are obtained with maximum precision.
Venous Thromboembolism Treatment Market Taxonomy
The global venous thromboembolism treatment market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach in front of the reader.
By Product
- Non-Segmented Pneumatic Compression Pumps
- Segmented Pneumatic Compression Pumps without Gradient
- Segmented Pneumatic Compression Pumps with Calibrated Gradient
- Upper Pneumatic Compression Sleeves
- Lower Pneumatic Compression Sleeves
- Permanent Inferior Vena Cava Filters
- Retrievable Inferior Vena Cava Filters
- Embolectomy Balloon Catheters
- Percutaneous Thrombectomy Devices
- Catheter-Directed Thrombolysis (CDT) Devices
By Disease Indication
- Deep Venous Thrombosis
- Pulmonary Embolism
By End User
- Hospitals
- Catheterisation Laboratories
- Ambulatory Surgical Centres
Region
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East & Africa
What's Included
The report commences with the executive summary of the venous thromboembolism treatment market, which includes a summary of the key findings and key statistics of the market. It also includes the market value (US$ million) estimates of the leading segments of the venous thromboembolism treatment market.
Readers can find the detailed taxonomy and the definition of the Venous Thromboembolism Treatment market in this chapter, which will help them understand the basic information about the venous thromboembolism treatment market. This section also highlights the inclusions and exclusions, which helps the reader understand the scope of the venous thromboembolism treatment market report.
The report provides key market trends that are expected to impact the market growth significantly during the forecast period. Detailed industry trends are provided in this section, along with key market development or product innovations.
This section includes the key inclusions of the report. It includes product adoption & usage analysis, reimbursement scenario, pipeline assessment & opportunity analysis, and manufactures strategies for market expansion.
This section explain the global market value analysis and forecast for the venous thromboembolism treatment market between the forecast periods of 2014-2029 is highlights in this section. This chapter includes the detailed analysis of the historical venous thromboembolism treatment market, along with an opportunity analysis of the future. Readers can also find the absolute opportunity for the current year (2019 – 2020), and an incremental opportunity for the forecast period (2019 – 2029).
This section highlights the average price of venous thromboembolism treatment. The pricing benchmark for manufacturer level pricing and distributor level pricing is analysed in this section.
This section explain the global market volume analysis and forecast for the Venous Thromboembolism Treatment market between the forecast periods of 2019-2029 is highlights in this section.
This chapter explains the key macro-economic factors that are expected to influence the growth of the Venous Thromboembolism Treatment market over the forecast period. Along with macroeconomic factors, this section also highlights the opportunity analysis for the Venous Thromboembolism Treatment market. This chapter also highlights the key market dynamics of the venous thromboembolism treatment market, which include the drivers, restraints and trends. Moreover, readers will understand the key trends followed by the leading manufacturers in the venous thromboembolism treatment market.
Based on product type, the venous thromboembolism treatment market is segmented into non-segmented pneumatic compression pumps, segmented pneumatic compression pumps without gradient, segmented pneumatic compression pumps with calibrated gradient, upper pneumatic compression sleeves, lower pneumatic compression sleeves, permanent inferior vena cava filters, retrievable inferior vena cava filters, embolectomy balloon catheters, percutaneous thrombectomy devices, catheter-directed thrombolysis (CDT) device In this chapter, readers can find information about the key trends and developments in the venous thromboembolism treatment market and market attractiveness analysis based on the product type.
This chapter provides details about the venous thromboembolism treatment market on the basis of disease indication, and has been classified into deep venous thrombosis and pulmonary embolism. In this chapter, readers can understand the market attractive analysis based on disease indication
This chapter provides details about the venous thromboembolism treatment market on the basis of end user, and has been classified into hospitals, catheterization laboratories and ambulatory surgical centers. In this chapter, readers can understand the market attractive analysis based on end user.
This chapter explains how the venous thromboembolism treatment market will grow across various geographic regions, such as North America, Latin America, Europe, East Asia, South Asia, Oceania, the Middle East & Africa (MEA)
This chapter includes a detailed analysis of the growth of the North America venous thromboembolism treatment market, along with a country-wise assessment that includes the U.S. and Canada. Readers can also find the regional trends, regulations, and market growth based on the end users and countries in North America.
Readers can find detailed information about several factors, such as the pricing analysis and the regional trends, which are impacting the growth of the Latin America venous thromboembolism treatment market. This chapter also includes the growth prospects of the venous thromboembolism treatment market in the leading LATAM countries such as Brazil, Mexico, Argentina, and the Rest of Latin America.
Important growth prospects of the venous thromboembolism treatment market based on its end users in several countries, such as Germany, the UK, France, Spain, Italy, Russia, and the Rest of Europe, are included in this chapter.
India, Indonesia, Thailand , Malaysia are the leading countries in the South Asia region that are the prime subjects of assessment to obtain the growth prospects of the South Asia venous thromboembolism treatment market in this chapter. Readers can find detailed information about the growth parameters of the South Asia venous thromboembolism treatment market during the period 2019-2029.
This chapter highlights the growth of the venous thromboembolism treatment market in the East Asia by focusing on China, Japan and South Korea. This section also helps readers understand the key factors that are responsible for the growth of the venous thromboembolism treatment market in East Asia.
In this chapter, Australia and New Zealand are among the leading countries in the Oceania region, which are the prime subjects of assessment to obtain the growth prospects of the Oceania venous thromboembolism treatment market.
This chapter provides information about how the venous thromboembolism treatment market will grow in the major countries in the MEA region, such as GCC Countries, South Africa, Turkey, Northern Africa and the rest of MEA, during the forecast period 2019 - 2029.
In this chapter, readers can find a detailed information about the tier analysis and market concentration of the key players in the venous thromboembolism treatment market along with their market presence analysis by region and product portfolio.
In this chapter, readers can find a comprehensive list of all the leading stakeholders in the Venous Thromboembolism Treatment market, along with detailed information about each company, which includes the company overview, revenue shares, strategic overview, and recent company developments. Some of the market players featured in the report are AngioDynamics, Boston Scientific Corp, Cardinal Health Inc., ArjoHuntleigh AB, BTG International Ltd., Stryker Corporation, DJO Global Inc., EKOS Corp, and Teleflex Inc.
This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the venous thromboembolism treatment report.
This chapter helps readers understand the research methodology followed to obtain the various conclusions as well as important qualitative and quantitative information about the venous thromboembolism treatment market.
How the research was conducted?
Primary Research
Primary research interview with Key Opinion Leaders and other participants were conducted for data collection and validation of the below information:
- Prevalence of Pulmonary Embolism.
- High Prevalence by Gender and Age-Group
- Treatment Seeking Rate
- Adoption of Venous Thromboembolism Treatment Devices as mode of treatment
- Average Selling Price (US$) and Market Growth
- Key Developments
- Key Trends and Opportunities
- Regional wise Dynamics
- Reimbursement Landscape
- Market Share Information
- Key Brands
- Competition & Key Vendor Strategies
Secondary Research
- National Blood Clot Alliance
- American Blood Clot Association
- The American Lung Association
- American Society of Hematology
- National Heart Blood And Lung Institute
- The Asia Pacific Vascular Society
- American Heart Association
- Annual Reports/SEC filings/Investor Presentations/Earning Call Transcript
- Industry Journals
Primary Interview Splits
Venous Thromboembolism Treatment Market Reports - Table of Contents
22. Assumptions and Acronyms Used
23. Research Methodology
Figure 01 : Global Venous Thromboembolism Treatment Market Revenue Share by Product Type, 2018A
Figure 02 : Global Venous Thromboembolism Treatment Market Revenue Share by Disease Indication Type, 2018A
Figure 03 : Global Venous Thromboembolism Treatment Market Revenue Share by End User, 2018A
Figure 04 : Global Venous Thromboembolism Treatment Market Revenue Share by Region, 2018A
Figure 05 : Global Venous Thromboembolism Treatment Market Historical Market Value (US$ Mn) Analysis, 2014–2018
Figure 06 : Global Venous Thromboembolism Treatment Current and Future Market Value (US$ Mn), 2019–2029 & Y-o-Y Growth Trend Analysis
Figure 07 : Venous Thromboembolism Treatment Market Absolute $ Opportunity, 2018–2029
Figure 08 : Global Venous Thromboembolism Treatment Market Attractiveness Analysis, By Product Type
Figure 09 : Global Venous Thromboembolism Treatment Market Attractiveness Analysis, By Disease Indication
Figure 10 : Global Venous Thromboembolism Treatment Market Attractiveness Analysis, By End User
Figure 11 : Global Venous Thromboembolism Treatment Market Attractiveness Analysis, Region
Figure 12 : North America Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis, 2014–2018
Figure 13 : North America Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2019–2029
Figure 14 : U.S. Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis, 2014-2018
Figure 15 : U.S. Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2019-2029
Figure 16 : Canada Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2014-2018
Figure 17 : Canada Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2019-2029
Figure 18 : North America Venous Thromboembolism Treatment Market Attractiveness Analysis, By Product Type
Figure 19 : North America Venous Thromboembolism Treatment Market Attractiveness Analysis, By Disease Indication
Figure 20 : North America Venous Thromboembolism Treatment Market Attractiveness Analysis, By End User
Figure 21 : North America Venous Thromboembolism Treatment Market Attractiveness Analysis, By Country
Figure 22 : Latin America Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis, 2014–2018
Figure 23 : Latin America Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2014–2018
Figure 24 : Brazil. Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis, 2014–2018
Figure 25 : Brazil Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2019-2029
Figure 26 : Mexico Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2014–2018
Figure 27 : Mexico Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2019-2029
Figure 28 : Rest of L.A Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis, 2014–2018
Figure 29 : Rest of L.A Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2019-2029
Figure 30 : Latin America Venous Thromboembolism Treatment Market Attractiveness Analysis, By Product Type
Figure 31 : Latin America Venous Thromboembolism Treatment Market Attractiveness Analysis, By Disease Indication
Figure 32 : Latin America Venous Thromboembolism Treatment Market Attractiveness Analysis, By End User
Figure 33 : Latin America Venous Thromboembolism Treatment Market Attractiveness Analysis, By Country
Figure 34 : Europe Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis, 2014–2018
Figure 35 : Europe Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2019–2029
Figure 36 : Germany Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis, 2014–2018
Figure 37 : Germany Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2019–2029
Figure 38 : France Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2019–2029
Figure 39 : France Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2019–2029
Figure 40 : U.K Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis, 2014–2018
Figure 41 : U.K Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2019–2029
Figure 42 : Italy Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2019–2029
Figure 43 : Italy Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2019–2029
Figure 44 : Russia Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis, 2014–2018
Figure 45 : Russia Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2019–2029
Figure 46 : Spain Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2019–2029
Figure 47 : Spain Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2019–2029
Figure 48 : BENELUX Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis, 2014–2018
Figure 49 : BENELUX Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2019–2029
Figure 50 : Rest of Europe Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2019–2029
Figure 51 : Rest of Europe Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2019–2029
Figure 52 : Europe Venous Thromboembolism Treatment Market Attractiveness Analysis, By Product Type
Figure 53 : Europe Venous Thromboembolism Treatment Market Attractiveness Analysis, By Disease Indication
Figure 54 : Europe Venous Thromboembolism Treatment Market Attractiveness Analysis, By End User
Figure 55 : Europe Venous Thromboembolism Treatment Market Attractiveness Analysis, By Country
Figure 56 : South Asia Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis, 2014–2018
Figure 57 : South Asia Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2019–2029
Figure 58 : Thailand Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis, 2014–2018
Figure 59 : Thailand Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2019–2029
Figure 60 : Malaysia Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2019–2029
Figure 61 : Malaysia Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2019–2029
Figure 62 : Indonesia Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis, 2014–2018
Figure 63 : Indonesia Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2019–2029
Figure 64 : India Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2019–2029
Figure 65 : India Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2019–2029
Figure 66 : Rest of South Asia Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis, 2014–2018
Figure 67 : Rest of South Asia Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2019-2029
Figure 68 : South Asia Venous Thromboembolism Treatment Market Attractiveness Analysis, By Product Type
Figure 69 : South Asia Venous Thromboembolism Treatment Market Attractiveness Analysis, By Disease Indication
Figure 70 : South Asia Venous Thromboembolism Treatment Market Attractiveness Analysis, By End User
Figure 71 : South Asia Venous Thromboembolism Treatment Market Attractiveness Analysis, By Country
Figure 72: East Asia Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis, 2014–2018
Figure 73 : East Asia Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2019–2029
Figure 74 : China. Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis, 2014–2018
Figure 75 : China. Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2019–2029
Figure 76 : Japan Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2019–2029
Figure 77 : Japan Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2019–2029
Figure 78 : South Korea Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis, 2014–2018
Figure 79 : South Korea Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2019-2029
Figure 80 : East Asia Venous Thromboembolism Treatment Market Attractiveness Analysis, By Product Type
Figure 81 : East Asia Venous Thromboembolism Treatment Market Attractiveness Analysis, By Disease Indication
Figure 82 : East Asia Venous Thromboembolism Treatment Market Attractiveness Analysis, By End User
Figure 83 : East Asia Venous Thromboembolism Treatment Market Attractiveness Analysis, By Country
Figure 84 : Oceania Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis, 2014–2018
Figure 85 : Oceania Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2019–2029
Figure 86 : Australia Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis, 2014–2018
Figure 87 : Australia Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2019–2029
Figure 88 : New Zealand Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2019–2029
Figure 89 : New Zealand Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2019–2029
Figure 90 : Oceania Venous Thromboembolism Treatment Market Attractiveness Analysis, By Product Type
Figure 91 : Oceania Venous Thromboembolism Treatment Market Attractiveness Analysis, By Disease Indication
Figure 92 : Oceania Venous Thromboembolism Treatment Market Attractiveness Analysis, By End User
Figure 93 : Oceania Venous Thromboembolism Treatment Market Attractiveness Analysis, By Country
Figure 94 : MEA Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis, 2014–2018
Figure 95 : MEA Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2019–2029
Figure 96: GCC Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis, 2014–2018
Figure 97 : GCC Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2019–2029
Figure 98 : Northern Africa Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2019–2029
Figure 99 : Northern Africa Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2019–2029
Figure 100 : South Africa Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis, 2014–2018
Figure 101 : South Africa Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2019–2029
Figure 102 : Rest of MEA Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2019–2029
Figure 103 : Rest of MEA Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast Analysis & Y-o-Y Growth (%), 2019–2029
Figure 104 : MEA Venous Thromboembolism Treatment Market Attractiveness Analysis, By Product Type
Figure 105 : MEA Venous Thromboembolism Treatment Market Attractiveness Analysis, By Disease Indication
Figure 106 : MEA Venous Thromboembolism Treatment Market Attractiveness Analysis, By End User
Figure 107 : MEA Venous Thromboembolism Treatment Market Attractiveness Analysis, By Country
Figure 108 : Global Vs. Emerging Venous Thromboembolism Treatment Market Value (%) Analysis 2014-2018 and Forecast 2019-2029
Figure 109 : China Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis, 2014–2018
Figure 110 : China Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2019–2029
Figure 111 : South Korea Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis, 2014–2018
Figure 112 : South Korea Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2019–2029
Figure 113 : India Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis, 2014–2018
Figure 114 : India Venous Thromboembolism Treatment Market Value (US$ Mn) Forecast & Y-o-Y Growth (%), 2019–2029
Table 01 : Global Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
Table 02 : Global Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
Table 03 : Global Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Disease Indication
Table 04 : Global Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
Table 05 : Global Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Region
Table 06 : North America Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
Table 07 : North America Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
Table 08 : North America Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
Table 09 : North America Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Disease Indication
Table 10 : North America Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
Table 11 : Latin America Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
Table 12 : Latin America Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
Table 13 : Latin America Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
Table 14 : Latin America Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Disease Indication
Table 15 : Latin America Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
Table 16 : Europe Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
Table 17 : Europe Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
Table 18 : Europe Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
Table 19 : Europe Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Disease Indication
Table 20 : Europe Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
Table 21 : South Asia Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
Table 22 : South Asia Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
Table 23 : South Asia Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
Table 24 : South Asia Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Disease Indication
Table 25 : South Asia Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
Table 26 : East Asia Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
Table 27 : East Asia Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
Table 28 : East Asia Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
Table 29 : East Asia Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Disease Indication
Table 30 : East Asia Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
Table 31 : Oceania Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
Table 32 : Oceania Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
Table 33 : Oceania Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
Table 34 : Oceania Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Disease Indication
Table 35 : Oceania Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
Table 36 : MEA Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
Table 37 : MEA Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
Table 38 : MEA Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
Table 39 : MEA Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Disease Indication
Table 40 : MEA Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
Table 41 : Emerging Venous Thromboembolism Treatment Market Value Proportion Analysis 2014-2018 and Forecast 2019-2029, By Country
Table 42 : Emerging and Global Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029
Table 43 : China Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
Table 44 : China Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
Table 45 : China Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Disease Indication
Table 46 : China Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
Table 47 : South Korea Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
Table 48 : South Korea Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
Table 49 : South Korea Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Disease Indication
Table 50 : South Korea Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
Table 51 : India Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
Table 52 : India Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
Table 53 : India Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Disease Indication
Table 54 : India Venous Thromboembolism Treatment Market Value (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
To Learn More About our Comprehensive Perspective on Venous Thromboembolism Treatment Demand Analysis, Contact Us
Get in touch
Harish Tiwari
Global Head - Business Development
Pranay Mhaisekar
Client Partner - Global Business Development
Our Clients
CASE STUDIES
See how our work makes an impact.
At FMI, we design strategies that are adaptive, impactful, and implementable.